期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

老年糖尿病隐匿性心肌缺血患者的动态血糖分析 被引量：2

Continuous glucose monitoring in patients of type 2 diabetic silent myocardial ischemia
原文传递
导出
摘要 目的:探讨老年2型糖尿病(T2DM)隐匿性心肌缺血(SMI)患者动态血糖波动的特点及临床意义。方法:85例老年受试者分为T2DM SMI组(35例)、单纯T2DM无SMI组(NSMI组,35例)和正常对照组(NC组,15例)3组,行72 h动态血糖监测,并对监测结果进行对比分析。结果:SMI组日内平均血糖波动幅度(MAGE)和血糖波动系数(BGFC)均明显高于NSMI组(P<0.05),夜间无症状低血糖发生率也明显升高(P<0.05)。结论:异常的血糖波动可能参与了老年T2DM患者SMI的发生与发展。 Objective： To investigate the greater details about the blood glucose fluctuation in senile patients with type 2 diabetic silent myocardial ischemia.Methods： 85 patients were divided into three groups：type 2 diabetic silent myocardial ischemia（n=35）,type 2 diabetes（n=35） and healthy control（n=15）.The fluctuating feature of the 72 hours blood glucose in three groups were compared by continuous glucose monitoring systems（CGMS）.Results： In patients with silent myocardial ischemia,the mean amplitude glycemic excursions（MAGE）,blood glucose fluctuant coefficient（BGFC） and incidence of asymptomatic hypoglycemia were significantly higher compared with patients of type 2 diabetes（P0.05）.Conclusion： The blood glucose fluctuation may play an important role in the pathogenesis of type 2 diabetic silent myocardial ischemia.
作者 彭朝胜 曹悦鞍 杨璐 夏菁 张文洛
机构地区 海军总医院特需医疗部
出处 《现代医学》 2012年第5期546-548,共3页 Modern Medical Journal
关键词 2型糖尿病 隐匿性心肌缺血 血糖波动 老年人 type 2 diabetes silent myocardial ischemia blood glucose fluctuation senile
分类号 R587.1 [医药卫生—内分泌]
  • 相关文献

参考文献11

  • 1刘洁,王尧.血糖波动与糖尿病并发症的关系[J].现代医学,2010,38(2):200-203. 被引量：35
  • 2MUGGEO M, VERLATO G, BONORA E, et al. Long-term instability of fasting plasma glucose, a novel predictor of cardi- ovascular mortality in elderly patients with non-insulin-de- pendent diabetes mellitus: the Verona Diabetes Study [ J ]. Circulation, 1997,96, (6) : 1750-1754.
  • 3彭朝胜,曹悦鞍,田力,张文洛,刘淑云.2型糖尿病患者颈动脉粥样硬化与动态血糖波动的关系[J].中国糖尿病杂志,2010,18(4):273-275. 被引量：15
  • 4黎雅清,李路.糖尿病无症状性心肌缺血的临床特点及诊治原则[J].中国糖尿病杂志,2006,14(1):70-70. 被引量：14
  • 5PICONI L, QUAGLIARO L, DAROS R. Intermittent high glu- cose enhances ICAM- 1, VCAM- 1, E- selectin and interleukin-6 expression in human umbilical endothelial ceils in culture:the role of poly ( ADP- ribose) polymerase [ J ]. J Thromb Haemost, 2004,2 : 1453-1459.
  • 6MONNIER L, MAS E, GINET C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes [ J ]. JAMA,2006,295 (14) : 1681-1687.
  • 7AZUMA K, KAWAMORI R, TOYOFUKU Y, et al. Repetitive fluctuations in blood glucose enhance monocyte adhesion to the endotheliumof rat thoracic aorta[ J ]. Arterioscler Thromb Vasc Bio1,2006,26(10) : 2275-2280.
  • 8QUAGLIARO L, PICONI L, ASSALONI R, et al. Intermittent high glucose enhances ICAM-1. VCAM-1 and E-selectin ex- pression in human umbilical vein endothelial cells in culture: the distinet role of protein kinase C and mitoehondrial superox- ide production [ J ]. Atherosclerosis, 2005,183 (2) :259- 267.
  • 9el OSTA A, BRASACCHIO D, YAO D, et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia [ J ]. J Exp Med, 2008,205 (10) :2409-2417.
  • 10HOLTHUSEN H, KOJDA G. Nitric oxide (NO) and pain. The role of NO in the origin and treatment of pain [ J ]. Med Monatsschr Pharm, 2000,23 ( 10 ) : 323- 328.

二级参考文献27

  • 1MONNIER L,MAS E,GINET C,et al.Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes[J].JAMA,2006,295(14):1681-1687.
  • 2GHANIM H,ALJADA A,HOFMEYER D,et al.Circulating mononuclear cells in the obese are in a proinflammatory state[J].Circulation,2004,110(12):1564-1571.
  • 3BURN E,ZOPP-INI G,ZAMBONI C,et al.Glucose instability is associated with a high level of circulating P-selectin[J].Diabetes Care,2001,24(9):1685-1699.
  • 4PICONI L,QUAGLIARO L,da ROS R,et al.Intermittent high glucose enhances ICAM-1,VCAM-1,E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture:the role of poly (ADP-ribose) polymerase[J].Thromb Haemost,2004,2(8):1453-1459.
  • 5AZUMA K,KAWAMORI R,TOYOFUKU Y,et al.Repetitive fluctuations in blood glucose enhance monocyte adhesion to the endothelium of rat thoracic aorta[J].Arterioscler Thromb Vasc Biol,2006,26(10):2275-2280.
  • 6KOVATCHEV B P,CLARKE W L,BRETON M,et al.Quantifying temporal glucose variability in diabetes via continuous glucose monitoring:mathematical methods and clinical application[J].Diabetes Technol Ther,2005,7(6):849-862.
  • 7CERIELLO A.Postprandial hyperglycemia and diabetes complications:is it time to treat?[J].Diabetes,2005,54(1):1-7.
  • 8HENIE R J,van GAAL L F,JOHN D,et al.Exenatide versus insulin gargine in patients with suboptimally controlled type 2 diabetes[J].Ann Intern Med,2005,143:559-569.
  • 9HIRSCH I B,BROWNLEE M.Should minimal blood glucose variability become the gold standard of glycemic control[J].Diabetes Complications,2005,19(3):178-181.
  • 10HAY L C,WILM-SHURST E G,FULCHER G.Unrecognized hypo-and hyperglycemia in well conctrolled patients with type 2 diabetes mellitus:the results of continuous glucose monitoring[J].Diabetes Technol Ther,2003,5:19-26.

共引文献64

同被引文献18

  • 1葛均波,徐永健.内科学.第8版.北京:人民卫生出版社,2013:553-556.
  • 2LAND H,SCHUTZ G,SCHMALE H,et al.Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin-neurophysin Ⅱ precursor[J].Nature,1982,295(5847):299-303.
  • 3BANKIR L,BARDOUX P,AHLOULAY M.Vasopressin and diabetes mellitus[J].Nephron,2001,87(1):8-18.
  • 4RIPHAGEN I J,BOERTIEN W E,ALKHALAF A,et al.Copeptin,a surrogate marker for arginine vasopressin,is associated with cardiovascular and all-cause mortality in patients with type 2 diabetes(ZODIAC-31)[J].Diabetes Care,2013,36(10):3201-3207.
  • 5MELLBIN L G,RYDEN L,BRISMAR K,et al.Copeptin,IGFBP-1,and cardiovascular prognosis in patients with type 2 diabetes and acute myocardial infarction:a report from the DIGAMI 2 trial[J].Diabetes Care,2010,33(7):1604-1606.
  • 6ZELLWEGER C,WILDI K,TWERENBOLD R,et al.Use of copeptin and high-sensitive cardiac troponin T for diagnosis and prognosis in patients with diabetes mellitus and suspected acute myocardial infarction[J].Int J Cardiol,2015,190:190-197.
  • 7HOLMES C L,LANDRY D W,GRANTON J T.Science review:vasopressin and the cardiovascular system part 2-clinical physiology[J].Crit Care,2004,8(1):15-23.
  • 8BABAR S I,BERG R A,HILWIG R W,et al.Vasopressin versus epinephrine during cardiopulmonary resuscitation:a randomized swine outcome study[J].Resuscitation,1999,41(2):185-192.
  • 9MORGENTHALER N G,STRUCK J,ALONSO C,et al.Assay for the measurement of copeptin,a stable peptide derived from the precursor of vasopressin[J].Clin Chem,2006,52(1):112-119.
  • 10ENHORNING S,WANG T J,NILSSON P M,et al.Plasma copeptin and the risk of diabetes mellitus[J].Circulation,2010,121(19):2102-2108.

引证文献2

二级引证文献8

现代医学
2012年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部